LOXL2 and pelvic inflammatory disease: The serum LOXL2 level was significantly higher in the PID patients [407.4 (351.8–456.2) pg/mL] compared with that in the healthy women [215.9 (196.0–247.4) pg/mL] (P < 0.001; Fig. 1A).